论文信息 - Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment? - 字舞流文

Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment?

K. Magyar | J. Knoll | B. Ekstedt

[1] A. Lees,et al. DEPRENYL IN PARKINSON'S DISEASE , 1977, The Lancet.

[2] L. Oreland,et al. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria. , 1976, Biochemical pharmacology.

[3] D. Laurence,et al. Monoamine oxidase inhibitors and L-dopa. , 1970, British medical journal.

[4] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[5] K. Magyar,et al. Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. , 1978, Biochemical pharmacology.